Fecal globin is the protein portion of human hemoglobin detected in a stool sample, used as a marker for hidden bleeding in the lower digestive tract. When blood enters the colon or rectum, intact hemoglobin molecules end up in the stool. The fecal immunochemical test (FIT), the most common colorectal cancer screening tool in use today, works by detecting this globin protein specifically.
How Globin Ends Up in Stool
Hemoglobin is the oxygen-carrying molecule inside red blood cells. It has two main parts: heme (an iron-containing ring) and globin (a protein chain). When a polyp, tumor, or other lesion in the colon bleeds, even in tiny amounts you’d never notice, whole hemoglobin molecules mix into the stool. The globin portion stays intact as it passes through the lower digestive tract, making it a reliable signal that bleeding is happening somewhere in the colon or rectum.
This is where fecal globin testing gets an important advantage. Digestive enzymes in the stomach and small intestine break down globin before it reaches the colon. That means if bleeding originates higher up, say from a stomach ulcer, the globin will be degraded by the time it reaches the stool. Studies confirm that immunochemical tests do not detect blood from upper gastrointestinal sources. The test is essentially tuned to pick up bleeding from the part of the digestive tract where colorectal cancers and precancerous polyps develop.
How the Test Detects It
The fecal immunochemical test uses antibodies designed to bind to human globin protein. In most lab systems, these are rabbit-derived antibodies specifically targeting human hemoglobin A. When you collect a stool sample using the provided kit, you scrape the surface of the stool with a small probe, coating the grooved tip, then seal it in a collection bottle. The lab runs the sample through an automated analyzer that measures how much human globin is present.
The result is quantitative. Labs measure the concentration of hemoglobin in micrograms per gram of stool. The standard threshold for a positive result is 20 micrograms per gram of feces, though some screening programs have lowered that cutoff to 10 micrograms per gram to catch more cancers at an earlier stage. Anything below the cutoff is reported as negative, meaning no significant bleeding was detected.
Why It Replaced the Older Stool Test
Before FIT became the standard, colorectal cancer screening relied on guaiac-based fecal occult blood tests. These older tests detect the heme portion of hemoglobin through a chemical reaction with a plant-based compound. The problem is that heme isn’t unique to human blood. Red meat contains heme, so eating a burger before the test could trigger a false positive. Raw fruits and vegetables with certain natural enzymes could also interfere. Even vitamin C supplements could cause false negatives by disrupting the chemical reaction. Patients had to follow dietary restrictions for three days before collecting a sample.
Fecal globin testing eliminated all of that. Because the antibodies target human globin specifically, no foods or supplements interfere with the result. There are no dietary restrictions before the test, no medications to stop, and no special preparation. This makes it far more practical for large-scale screening programs and significantly more likely that people will actually complete the test.
The accuracy improvement is meaningful too. In screening populations, FIT detects colorectal cancer with roughly 75% sensitivity and 90% specificity, compared to about 50% sensitivity and 78% specificity for guaiac-based tests. FIT also picks up advanced precancerous polyps (advanced adenomas) at a rate of 20% to 40%, catching some growths before they become cancerous.
What a Positive Result Means
A positive fecal globin test means human blood was detected in your stool above the threshold, but it does not mean you have cancer. Colorectal cancer is actually one of the less common reasons for a positive result. Hemorrhoids and non-cancerous conditions like inflammatory bowel disease, diverticular disease, or ulcers in the colon are more frequent causes. The test cannot distinguish between blood from a harmless hemorrhoid and blood from a tumor, so a positive result leads to a follow-up colonoscopy to identify the source.
A negative result is reassuring but not absolute. Small or non-bleeding polyps won’t release enough blood to trigger the test, and some cancers bleed intermittently. This is why screening guidelines from the U.S. Preventive Services Task Force recommend repeating the FIT every year for adults at average risk. Annual testing catches intermittent bleeding over time, substantially improving the odds of detection compared to a single test.
How to Collect the Sample
FIT kits come with a specific collection bottle and a probe with a grooved tip. You collect the sample at home after a bowel movement, scraping the surface of the stool to coat the grooved portion of the probe. The sample needs to avoid contact with toilet water, which can dilute or contaminate it. Once sealed, the bottle should be returned to the lab promptly, typically within a few days, because globin degrades over time, especially in warm temperatures. Heat exposure during storage or transport can break down the protein and lead to a falsely negative result.
Only the manufacturer’s specific collection bottle is accepted. You cannot substitute a different container, because the bottle contains a buffer solution designed to stabilize the globin protein until the lab processes it.
Where Fecal Globin Testing Fits in Screening
For adults at average risk of colorectal cancer, the USPSTF recommends screening starting at age 45 using one of several approved methods. Annual FIT is one of the primary options, alongside colonoscopy every 10 years or a combined stool DNA-FIT test every 1 to 3 years. Each approach has trade-offs in convenience, cost, and detection rates, but FIT’s simplicity and lack of preparation requirements make it the most accessible option for routine yearly screening. It requires no sedation, no bowel prep, no time off work, and no visit to a medical facility for the collection itself.